NM_000388.4(CASR):c.2325C>G (p.Phe775Leu) AND Nephrolithiasis/nephrocalcinosis

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Dec 4, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004026511.1

Allele description [Variation Report for NM_000388.4(CASR):c.2325C>G (p.Phe775Leu)]

NM_000388.4(CASR):c.2325C>G (p.Phe775Leu)

Gene:

CASR:calcium sensing receptor [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

3q21.1

Genomic location:

Preferred name:

NM_000388.4(CASR):c.2325C>G (p.Phe775Leu)

HGVS:

NC_000003.12:g.122284279C>G
NG_009058.1:g.105597C>G
NM_000388.4:c.2325C>GMANE SELECT
NM_001178065.2:c.2355C>G
NP_000379.3:p.Phe775Leu
NP_001171536.2:p.Phe785Leu
NC_000003.11:g.122003126C>G
NM_000388.3:c.2325C>G

Protein change:

F775L

Links:

dbSNP: rs767586088

NCBI 1000 Genomes Browser:

rs767586088

Molecular consequence:

NM_000388.4:c.2325C>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001178065.2:c.2355C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:: Nephrolithiasis/nephrocalcinosis
Identifiers:: MedGen: CN580796

Recent activity

Clear Turn Off Turn On

growth arrest-specific protein 2 isoform X1 [Homo sapiens]
growth arrest-specific protein 2 isoform X1 [Homo sapiens]
gi|2217282244|ref|XP_047282700.1|

Protein
Mus musculus partial mRNA for B-Raf protein (B-raf gene), alternative exon 10
Mus musculus partial mRNA for B-Raf protein (B-raf gene), alternative exon 10
gi|7271250|emb|AJ276309.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003855442	Ambry Genetics	criteria provided, single submitter (Ambry Variant Classification Scheme 2023)	Uncertain significance (Dec 4, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003855442

Ambry Genetics

criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)

Uncertain significance
(Dec 4, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV003855442.2

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

The p.F775L variant (also known as c.2325C>G), located in coding exon 6 of the CASR gene, results from a C to G substitution at nucleotide position 2325. The phenylalanine at codon 775 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 3, 2024

ClinVar

Relating variation to medicine